Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

Eur Heart J. 2022;43(6):474.

Enlaces

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830527/

Inicie sesión para enviar comentarios

Artículos Relacionadas

Expert Consensus on Morphofunctional Assessment in Disease-Related Malnutrition. Grade Review and Delphi Study

Association of Phase Angle with Overall Survival in Patients with Cancer: A Prospective Multicenter Cohort Study

MODY probability calculator utility in individuals' selection for genetic testing: Its accuracy and performance

MODY probability calculator utility in individuals' selection for genetic testing: Its accuracy and performance

Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Standards of Care in Diabetes—2023

Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica: 2021 (SEN-MM)

Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer

Once-Weekly Semaglutide in Adolescents with Obesity

Agenda

Febrero 2023

Lun	Mar	Mié	Jue	Vie	Sáb	Dom
30	31	1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	1	2	3	4	5

Top